RICARDO LEYVA: Open Payments
NPI 1427436849 · MCKINNEY, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,297 in 119 payments from 18 companies in 2025. Trend: 2023 $1,918 · 2024 $1,922 · 2025 $2,297
Food & beverage: $2,297
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 11 | $276 |
| AstraZeneca Pharmaceuticals LP | 10 | $240 |
| Bayer Healthcare Pharmaceuticals Inc. | 11 | $200 |
| GlaxoSmithKline, LLC. | 11 | $195 |
| Novo Nordisk Inc | 9 | $182 |
| ABBVIE INC. | 10 | $176 |
| Amgen Inc. | 12 | $154 |
| Merck Sharp & Dohme LLC | 8 | $152 |
| Takeda Pharmaceuticals U.S.A., Inc. | 7 | $147 |
| Lilly USA, LLC | 5 | $111 |
Products named: IBSRELA, Kerendia, TRELEGY ELLIPTA, TRINTELLIX, VERQUVO, AIRSUPRA, OTEZLA, JARDIANCE.
Industry payments across TX — which companies pay providers there.
